On Thursday, Bluebird Bio Inc. (NASDAQ:BLUE) reported a third-quarter EPS loss of 31 cents, compared to a loss of 80 cents a ...

J.P. Morgan upgraded shares of networking company Cisco to Overweight from Neutral, and raised the target price to $66 from ...

Fintel reports that on November 14, 2024, JP Morgan initiated coverage of Blueprint Medicines (NasdaqGS:BPMC) with a ...

With 2025 on the horizon, investors are sharpening their focus on the year ahead, selecting portfolio additions that aim to bring solid ...

J.P. Morgan Chase is focused on supporting the growth of companies along the Front Range of the Rockies by advising on ...

J.P. Morgan analyst Lisa Gill maintained a Hold rating on Humana (HUM – Research Report) yesterday and set a price target of $257.00. The ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 8.96% of ...

Previously called Onyx, JP Morgan has refreshed its network under the Kinexys name as it rolls out new infrastructure and capabilities.

After the company's earnings last Friday, shares of the largest insurer Life Insurance Corporation of India (LIC) traded on a ...

JP Morgan Asset Management (JPMAM) has introduced access to the JP Morgan Private Markets Strategy for Canadian accredited ...

Year-to-date, NMDC's shares have gained over 6 percent but have trailed behind the Nifty 50, which has risen by 11 percent.

Shares of Springer Nature (F: SPGG) jumped following J.P. Morgan’s initiation of coverage with an "overweight" rating and a price target of €29 in a note date ...